Roche
PulseAugur coverage of Roche — every cluster mentioning Roche across labs, papers, and developer communities, ranked by signal.
- 2026-10-12 product_launch Roche announced an AI expansion plan to accelerate drug discovery and development. source
2 day(s) with sentiment data
-
Biotech IPOs surge with over two dozen companies public this year
The biotech sector has seen a significant increase in companies going public this year, with over two dozen already having completed their IPOs. This trend is expected to continue, with more companies preparing to enter…
-
Roche accelerates drug discovery with AI expansion plan
Roche is implementing an AI expansion plan aimed at speeding up drug discovery and development processes. This initiative involves strategic investments to enhance research and development productivity. The company anti…
-
AI Enhances Antibody Design, But Lab Work Remains Crucial
Artificial intelligence has shown promise in enhancing the design of therapeutic antibodies, according to a recent study. While AI can improve existing drug candidates, the research emphasizes that traditional laborator…
-
New two-step method simplifies antibody-drug conjugate creation for cancer therapies
Researchers have developed a novel two-step process for creating more uniform antibody-drug conjugates (ADCs). This method precisely attaches cancer drugs to a specific site on antibodies, streamlining the development o…
-
Dataiku executive outlines AI business value strategy: People, orchestration, governance
Sophie Dionnet of Dataiku discussed how to translate AI into tangible business value, emphasizing that the key lies not solely in technology but in people, orchestration, and robust governance for scalability. She highl…
-
Dataiku's Sophie Dionnet: People, Orchestration, Governance Key to Enterprise AI Value
Sophie Dionnet from Dataiku, featured on the Analyse Podcast, discussed that the true value of enterprise AI stems not solely from the technology itself, but from a combination of factors. She emphasized the critical ro…
-
Thyme Care founder steps down as CEO amid strong growth
Thyme Care, a startup focused on helping patients navigate cancer care, is undergoing a leadership transition. Founder Robin Shah will step down as CEO on September 1st, with Dr. Brad Diephuis, the company's co-presiden…
-
Swiss population cap vote could limit international talent for major firms
Switzerland is set to vote on a referendum that could implement the world's first national population cap, potentially limiting the population to 10 million by 2050. Major companies like Roche and Nestlé, along with the…
-
Roche survey: Diabetes significantly impacts mental health globally
A global survey by Roche reveals that a significant majority of people with diabetes experience negative impacts on their emotional well-being, with 66% reporting that the condition affects their mental health. The stud…
-
Roche developer slashes GPU pod cold starts from 15 to 4 minutes
A developer at Roche significantly improved GPU pod cold start times, reducing them from approximately 15 minutes to around 4 minutes. This optimization was achieved by rebuilding a specific pattern to enhance efficienc…